| Connecting bioconjugate science, technology, and application across industries Bioconjugate Insights is an open-access, peer-reviewed journal providing industry-aligned strategic analysis and technical updates across the bioconjugate field. Covering ADCs, linker, and payload innovation, conjugation chemistry, analytics, regulation, and manufacturing. We connect research with translational and commercial perspectives to support smarter development of bioconjugate therapies. Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the cutting edge of bioconjugate innovation. |  |
| Expert-led content on translation and commercialization in life sciences BioInsights brings together peer-reviewed insights, expert analysis, and industry perspectives from across the biopharma landscape, spanning the cell and gene therapy, nucleic acids, vaccines, and bioconjugates fields, from early discovery through to clinical development and commercialization. Contact us to see how we can partner with you. Contact us |  |
| Cutting through the noise in RNA and DNA therapeutics Nucleic Acid Insights is an online, open-access, peer-reviewed journal delivering the latest expert analysis and technical insight across the rapidly evolving nucleic acid landscape. Covering the discovery, development, manufacture, formulation, and delivery of modalities including oligonucleotides, plasmid and synthetic DNA, and RNA-LNPs. Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the cutting edge of nucleic acid innovation. |  |
| Essential insights to advance vaccine development and delivery Vaccine Insights is an online, open-access, peer-reviewed journal covering the latest advances in vaccine R&D, formulation, regulation, immunology, manufacturing, QA/QC and pandemic preparedness. Guided by an expert advisory board, the journal brings together insights on emerging vaccine technologies, next-generation platforms, and transformative approaches reshaping how vaccines are discovered, developed and delivered. Sign-up for free to gain unlimited access to our extensive collection of articles, webinars, podcasts, news, and interviews, and remain at the forefront of vaccine innovation. |  |
Closed Publications
Immuno-Oncology Insights has ceased publication. However, all published content remains available here. |
Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.
To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.